Hyperbaric oxygen therapy's impact on cardiac function
Jerusalem Post - 04-Feb-2020Protocols were evaluated on the patients with “normal” aging heart
Join the club for FREE to access the whole archive and other member benefits.
One of the largest Hyperbaric centers worldwide
The Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center (Assaf Harofeh) was established in 1997 and operates the largest and most sophisticated multiplace hyperbaric oxygen chambers globally. The chambers provide hyperbaric oxygen therapy (HBOT) treatment to help people suffering from a variety of medical conditions. Though HBOT treatment is classically used to treat chronic non-healing wounds and other acute indications such as decompression sickness, CO intoxication, and acute retinal artery occlusion, the Sagol Center has taken a leading role in pioneering research on the treatment’s regenerative effects and ability to induce neuroplasticity. This has allowed the Center to treat patients for a variety of additional complex cognitive conditions such as:
Age related functional and cognitive decline, stroke, Traumatic Brain Injury (TBI), and chronic pain syndrome.
Visit website: https://www.shamir.org/en/clinic-pages-default-aspx/the-sagol-center-for-hyperbaric-medicine-and-research/
See also: Shamir Medical Center - The fourth largest government hospital in Israel
Details last updated 05-Feb-2020
Shai Efrati is an Israeli physician, an associate professor at the Sackler Faculty of Medicine and the Sagol School of Neuroscience
Protocols were evaluated on the patients with “normal” aging heart